GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Net Income Including Noncontrolling Interests

Cantourage Group SE (XTER:HIGH) Net Income Including Noncontrolling Interests : €0.03 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Cantourage Group SE's Net Income Including Noncontrolling Interests for the six months ended in Jun. 2023 was €0.01 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2023 was €0.03 Mil.

Cantourage Group SE Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Cantourage Group SE's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE Net Income Including Noncontrolling Interests Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Net Income Including Noncontrolling Interests
-0.18 -0.59 -0.97 0.01

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial - - -0.01 0.02 0.01

Cantourage Group SE Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantourage Group SE Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantourage Group SE (XTER:HIGH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
Traded in Other Exchanges
HIGH:Germany
Address
Feurigstrasse 54, Berlin, DEU, 10827
Website
https://www.cantourage.com
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines